Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
Cell & Gene Therapy
Biotech
Minovia skates SPAC-wards into public market
The Israeli biotech is planning to merge with publicly listed Launch One Acquisition.
Gabrielle Masson
Jun 25, 2025 10:33am
Fierce Pharma
FDA investigates 2 deaths after Sarepta Duchenne gene therapy
Jun 25, 2025 10:26am
Biogen to take Spinraza follow-up into registrational studies
Jun 25, 2025 8:04am
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs
Jun 25, 2025 7:46am
Cash-strapped Sangamo seeks partner for new gene therapy
Jun 24, 2025 11:53am
Vertex diabetes islet cell therapy improves blood sugar levels
Jun 23, 2025 4:21am
More News
Industry disappointed as FDA reportedly puts Verdun on leave
Jun 20, 2025 1:53am
Eli Lilly pays $1B upfront to buy gene editing partner Verve
Jun 17, 2025 4:35am
Fierce Pharma
2nd patient dies after Sarepta's DMD gene therapy Elevidys
Jun 16, 2025 10:58am
J&J lymphoma CAR-T hits 100% ORR in 10 patients
Jun 13, 2025 1:22pm
See more stories
